These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 30085126)
21. Functional selectivity and classical concepts of quantitative pharmacology. Urban JD; Clarke WP; von Zastrow M; Nichols DE; Kobilka B; Weinstein H; Javitch JA; Roth BL; Christopoulos A; Sexton PM; Miller KJ; Spedding M; Mailman RB J Pharmacol Exp Ther; 2007 Jan; 320(1):1-13. PubMed ID: 16803859 [TBL] [Abstract][Full Text] [Related]
22. A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes. Michel MC; Michel-Reher MB; Hein P Cells; 2020 Aug; 9(9):. PubMed ID: 32825009 [TBL] [Abstract][Full Text] [Related]
23. Inverse agonism: more than reverting constitutively active receptor signaling. Dupré DJ; Rola-Pleszczynski M; Stanková J Biochem Cell Biol; 2004 Dec; 82(6):676-80. PubMed ID: 15674435 [TBL] [Abstract][Full Text] [Related]
24. Inverse, protean, and ligand-selective agonism: matters of receptor conformation. Kenakin T FASEB J; 2001 Mar; 15(3):598-611. PubMed ID: 11259378 [TBL] [Abstract][Full Text] [Related]
25. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery. Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634 [TBL] [Abstract][Full Text] [Related]
26. Efficacy as a vector: the relative prevalence and paucity of inverse agonism. Kenakin T Mol Pharmacol; 2004 Jan; 65(1):2-11. PubMed ID: 14722230 [TBL] [Abstract][Full Text] [Related]
38. Some implications of receptor theory for in vivo assessment of agonists, antagonists and inverse agonists. Negus SS Biochem Pharmacol; 2006 Jun; 71(12):1663-70. PubMed ID: 16460689 [TBL] [Abstract][Full Text] [Related]
39. Development of new drugs that act through membrane receptors and involve an action of inverse agonism. Rodríguez-Puertas R; Barreda-Gómez G Recent Pat CNS Drug Discov; 2006 Jun; 1(2):207-17. PubMed ID: 18221203 [TBL] [Abstract][Full Text] [Related]
40. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Bond RA; Ijzerman AP Trends Pharmacol Sci; 2006 Feb; 27(2):92-6. PubMed ID: 16406086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]